Search Within

Franz A. Schmid

Formats
  1. Journal Article (21)
  2. Meeting Abstract (5)
People
  1. Glenys Otter (16)
  2. Francis Sirotnak (11)
  3. Adam Dicker (1)
  4. Alan Gelbard (1)
  5. Barry Schweitzer (1)
  6. Bipin Mehta (1)

More People

Years
  1. 1993 (2)
  2. 1990 (1)
  3. 1989 (1)
  4. 1988 (3)
  5. 1987 (3)
  6. 1986 (6)

More Years

Publications
  1. Cancer Research (8)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (5)
  3. Journal of Medicinal Chemistry (4)
  4. Cancer Treatment Reports (2)
  5. Biochimica et Biophysica Acta (BBA) - General Subjects (1)
  6. Cancer Biochemistry Biophysics (1)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. American Chemical Society (4)
  3. National Cancer Institute (2)
  4. Cognizant Communication Corporation (1)
  5. Elsevier B.V. (1)
  6. Elsevier Inc. (1)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation
    Journal Article

    Dicker, A. P.; Waltham, M. C.; Volkenandt, M.; Schweitzer, B. I.; Otter, G. M.; Schmid, F. A.; Sirotnak, F. M.; Bertino, J. R.
    Proceedings of the National Academy of Sciences of the United States of America (1993)

    Fulltext@MSK | Save
  • Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors
    Journal Article

    Sirotnak, F. M.; Otter, G. M.; Schmid, F. A.
    Cancer Research (1993)

    Fulltext@MSK | Save
  • Preferential selection during therapy in vivo by edatrexate compared to methotrexate of resistant L1210 cell variants with decreased folylpolyglutamate synthetase activity
    Journal Article

    Rumberger, B. G.; Schmid, F. A.; Otter, G. M.; Sirotnak, F. M.
    Cancer Communications (1990)

    Fulltext@MSK | Save
  • Intracavitary therapy of murine ovarian cancer with cis-diamminedichloro-platinum(II) and 10-ethyl-10-deazaaminopterin incorporating systemic leucovorin protection
    Journal Article

    Sirotnak, F. M.; Schmid, F. A.; DeGraw, J. I.
    Cancer Research (1989)

    Fulltext@MSK | Save
  • Characterization of L1210 methylnitrosourea lines with respect to drug resistance and tumorigenicity
    Meeting Abstract

    Schmid, F. A.; Otter, G. M.; Dodd, K. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (1988)

    Fulltext@MSK | Save
  • L1210 leukemia hybrids isolated after fusion of alkylating agent-resistant sublines
    Journal Article

    Schmid, F. A.; Otter, G. M.; Hirano, I.
    Leukemia Research (1988)

    Fulltext@MSK | Save
  • Structural design, biochemical properties, and evidence for improved therapeutic activity of 5-alkyl derivatives of 5-deazaaminopterin and 5-deazamethotrexate compared to methotrexate in murine tumor models
    Journal Article

    Sirotnak, F. M.; Schmid, F. A.; Otter, G. M.; Piper, J. R.; Montgomery, J. A.
    Cancer Research (1988)

    Fulltext@MSK | Save
  • Combination chemotherapy with a new folate analog, 10-ethyl-10-deaza-aminopterin (10EDAM), against advanced metastatic disease in murine tumor models
    Meeting Abstract

    Schmid, F. A.; Sirotnak, F. M.; Otter, G. M.; Degraw, J. I.
    Proceedings of the American Association for Cancer Research Annual Meeting (1987)

    Fulltext@MSK | Save
  • Combination chemotherapy with a new folate analog: Activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models
    Journal Article

    Schmid, F. A.; Sirotnak, F. M.; Otter, G. M.; Degraw, J. I.
    Cancer Treatment Reports (1987)

    Fulltext@MSK | Save
  • 10-ethyl-10-deaza-aminopterin: Structural design and biochemical, pharmacologic, and antitumor properties
    Journal Article

    Sirotnak, F. M.; Schmid, F. A.; Samuels, L. L.; DeGraw, J. I.
    NCI Monographs (1987)

    Fulltext@MSK | Save